Nasamon Wanlapakorn
About
Nasamon Wanlapakorn is a scholar working on Infectious Diseases, Epidemiology and Hepatology.
According to data from OpenAlex, Nasamon Wanlapakorn has authored 106 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Infectious Diseases, 48 papers in Epidemiology and 19 papers in Hepatology. Recurrent topics in Nasamon Wanlapakorn's work include SARS-CoV-2 and COVID-19 Research (38 papers), Hepatitis B Virus Studies (18 papers) and COVID-19 Clinical Research Studies (17 papers). Nasamon Wanlapakorn is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (38 papers), Hepatitis B Virus Studies (18 papers) and COVID-19 Clinical Research Studies (17 papers). Nasamon Wanlapakorn collaborates with scholars based in Thailand, United Kingdom and Belgium. Nasamon Wanlapakorn's co-authors include Yong Poovorawan, Sompong Vongpunsawad, Jiratchaya Puenpa, Preeyaporn Vichaiwattana, Thanunrat Thongmee, Jira Chansaenroj, Nungruthai Suntronwong, Chompoonut Auphimai, Ritthideach Yorsaeng and Donchida Srimuan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.
In The Last Decade
Nasamon Wanlapakorn
99 papers receiving 1.4k citations
Peers
Nasamon Wanlapakorn
Karin Hardt Belgium
Brigitte Cheuvart Belgium
Talat Mokhtari‐Azad Iran
Vana Spoulou Greece
Mohamed Al‐Ibrahim United States
Luc Hessel France
Thanunrat Thongmee Thailand
Yuliang Zhao China
Eithne MacMahon United Kingdom
Hongxing Pan China
Citations per year, relative to Nasamon Wanlapakorn Nasamon Wanlapakorn (= 1×)
peers
Karin Hardt
Countries citing papers authored by Nasamon Wanlapakorn
Since
Specialization
Citations
This map shows the geographic impact of Nasamon Wanlapakorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nasamon Wanlapakorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nasamon Wanlapakorn more than expected).
Fields of papers citing papers by Nasamon Wanlapakorn
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Nasamon Wanlapakorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nasamon Wanlapakorn. The network helps show where Nasamon Wanlapakorn may publish in the future.
Co-authorship network of co-authors of Nasamon Wanlapakorn
This figure shows the co-authorship network connecting the top 25 collaborators of Nasamon Wanlapakorn. A scholar is included among the top collaborators of Nasamon Wanlapakorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nasamon Wanlapakorn. Nasamon Wanlapakorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Nakphaichit, Massalin, Wanwipa Vongsangnak, Sittiruk Roytrakul, et al.. (2025). Dysbiosis involving methionine and PPAR-γ pathways is associated with early onset atopic dermatitis and food allergy. Asian Pacific Journal of Allergy and Immunology. 43(4). 908–920.
2.
Suntronwong, Nungruthai, Sitthichai Kanokudom, Chompoonut Auphimai, et al.. (2024). Long-Term Dynamic Changes in Hybrid Immunity over Six Months after Inactivated and Adenoviral Vector Vaccination in Individuals with Previous SARS-CoV-2 Infection. Vaccines. 12(2). 180–180.
3.
Wanlapakorn, Nasamon, et al.. (2024). Persistence of Antibodies against Measles, Mumps, and Rubella after the Two-Dose MMR Vaccination: A 7-Year Follow-Up Study. Vaccines. 12(7). 744–744.
4.
Chaithongwongwatthana, Surasith, et al.. (2024). Transplacental transfer of maternal antibodies following immunization with recombinant pertussis vaccines during pregnancy: Real-world evidence. International Journal of Infectious Diseases. 144. 107047–107047.
5.
Wanlapakorn, Nasamon, et al.. (2023). Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age. Vaccine. 41(26). 3855–3861.
6.
Wanlapakorn, Nasamon, Ilada Thongpan, Preeyaporn Vichaiwattana, et al.. (2023). Epidemiology and clinical characteristics of severe acute respiratory infections among hospitalized children under 5 years of age in a tertiary care center in Bangkok, Thailand, 2019–2020. Heliyon. 9(11). e22300–e22300.
7.
Kanokudom, Sitthichai, Jira Chansaenroj, Nungruthai Suntronwong, et al.. (2023). The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5. Vaccines. 11(3). 570–570.
8.
Suntronwong, Nungruthai, Sitthichai Kanokudom, Suvichada Assawakosri, et al.. (2023). Neutralizing antibodies against Omicron BA.5 among children with infection alone, vaccination alone, and hybrid immunity. International Journal of Infectious Diseases. 134. 18–22.
9.
Wanlapakorn, Nasamon, Nungruthai Suntronwong, Ritthideach Yorsaeng, et al.. (2022). Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study. Human Vaccines & Immunotherapeutics. 18(1). 2029111–2029111.
10.
Assawakosri, Suvichada, Sitthichai Kanokudom, Nungruthai Suntronwong, et al.. (2022). Neutralizing Activities Against the Omicron Variant After a Heterologous Booster in Healthy Adults Receiving Two Doses of CoronaVac Vaccination. The Journal of Infectious Diseases. 226(8). 1372–1381.
11.
Sathitratanacheewin, Seelwan, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, et al.. (2022). Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis. Lupus Science & Medicine. 9(1). e000726–e000726.
12.
Thongpan, Ilada, Preeyaporn Vichaiwattana, Thanunrat Thongmee, et al.. (2022). High seroprevalence of antibodies against human respiratory syncytial virus and evidence of respiratory syncytial virus reinfection in young children in Thailand. International Journal of Infectious Diseases. 125. 177–183.
13.
Suntronwong, Nungruthai, Ritthideach Yorsaeng, Jiratchaya Puenpa, et al.. (2022). COVID-19 Breakthrough Infection after Inactivated Vaccine Induced Robust Antibody Responses and Cross-Neutralization of SARS-CoV-2 Variants, but Less Immunity against Omicron. Vaccines. 10(3). 391–391.
14.
Assawakosri, Suvichada, Sitthichai Kanokudom, Jira Chansaenroj, et al.. (2022). Persistence of immunity against Omicron BA.1 and BA.2 variants following homologous and heterologous COVID-19 booster vaccines in healthy adults after a two-dose AZD1222 vaccination. International Journal of Infectious Diseases. 122. 793–801.
15.
Kanokudom, Sitthichai, Suvichada Assawakosri, Nungruthai Suntronwong, et al.. (2022). Safety and Immunogenicity of the Third Booster Dose with Inactivated, Viral Vector, and mRNA COVID-19 Vaccines in Fully Immunized Healthy Adults with Inactivated Vaccine. Vaccines. 10(1). 86–86.
16.
Triukose, Sipat, et al.. (2021). Effects of public health interventions on the epidemiological spread during the first wave of the COVID-19 outbreak in Thailand. PLoS ONE. 16(2). e0246274–e0246274.
17.
Posuwan, Nawarat, Nasamon Wanlapakorn, Sompong Vongpunsawad, et al.. (2020). Comparison of hepatitis B surface antibody levels induced by the pentavalent DTwP-HB-Hib versus the hexavalent DTaP-HB-Hib-IPV vaccine, administered to infants at 2, 4, 6, and 18 months of age, following monovalent hepatitis B vaccination at birth. Vaccine. 38(7). 1643–1651.
18.
Wanlapakorn, Nasamon, Kirsten Maertens, Surasith Chaithongwongwatthana, et al.. (2018). Assessing the reactogenicity of Tdap vaccine administered during pregnancy and antibodies to Bordetella pertussis antigens in maternal and cord sera of Thai women. Vaccine. 36(11). 1453–1459.
19.
Theamboonlers, Apiradee, et al.. (2015). NOROVIRUS OUTBREAK AT A DAYCARE CENTER IN BANGKOK, 2014.. PubMed. 46(4). 616–23.
20.
Wanlapakorn, Nasamon, Pornsak Yoocharoen, Piyanit Tharmaphornpilas, Apiradee Theamboonlers, & Yong Poovorawan. (2014). Diphtheria outbreak in Thailand, 2012; seroprevalence of diphtheria antibodies among Thai adults and its implications for immunization programs.. PubMed. 45(5). 1132–41.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Karin Hardt Breakdown of academic impact, for papers by Brigitte Cheuvart Breakdown of academic impact, for papers by Talat Mokhtari‐Azad Breakdown of academic impact, for papers by Vana Spoulou Breakdown of academic impact, for papers by Mohamed Al‐Ibrahim Breakdown of academic impact, for papers by Luc Hessel Breakdown of academic impact, for papers by Thanunrat Thongmee Breakdown of academic impact, for papers by Yuliang Zhao Breakdown of academic impact, for papers by Eithne MacMahon Breakdown of academic impact, for papers by Hongxing Pan